+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Smart Insulin Pens & Pumps Market by Product Type, Treatment Type, Distribution Channel, Diabetes Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460287
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Smart Insulin Pens & Pumps Market grew from USD 1.51 billion in 2024 to USD 1.67 billion in 2025. It is expected to continue growing at a CAGR of 9.98%, reaching USD 2.68 billion by 2030.

Navigating the Evolution of Smart Insulin Delivery Solutions

The landscape of diabetes management has been irreversibly transformed by the advent of smart insulin pens and pumps, ushering in an era of precision care that empowers patients and clinicians alike. As traditional insulin delivery devices give way to connected, data-driven solutions, stakeholders across the healthcare continuum are recalibrating their strategies to harness the potential of real-time dosing analytics, remote monitoring, and personalized therapy regimens. This report delves into the forces shaping the current market, offering decision-makers a panoramic view of opportunities and challenges. By weaving together technological advancements, regulatory dynamics, and evolving patient expectations, we set the stage for a nuanced exploration of how smart delivery systems are redefining glycemic control.

Our introduction not only outlines the critical innovations driving this segment but also underscores the imperative for agility in product development and commercial execution. As digital health continues to converge with traditional medical devices, the interplay between software, hardware, and data security demands meticulous attention. In the pages that follow, readers will gain a foundational understanding of market drivers, emerging use-cases, and the strategic imperatives that are steering investment flows. This section serves as a primer to align stakeholders on the transformative impact of connected insulin delivery solutions and to frame the detailed analysis presented throughout the report.

Unveiling Paradigm-Shifting Trends Shaping Insulin Delivery Technology

The insulin delivery landscape is experiencing a seismic shift as connectivity and intelligence become integral to device design and patient engagement. Where once insulin pens and pumps were purely mechanical, today’s generation incorporates wireless connectivity, cloud-based dosing records, and predictive dosing algorithms. Wearable sensors now communicate seamlessly with companion apps to deliver contextual insights, flagging patterns of hypo- or hyperglycemia before they escalate.

Regulatory frameworks are evolving in parallel, embracing digital health certifications and fast-track pathways for interoperable systems. Notably, agencies are prioritizing cybersecurity guidelines and data privacy standards, acknowledging that the safety of insulin delivery devices is inextricable from the integrity of their software ecosystems. Moreover, the rise of value-based care models is incentivizing outcome-oriented features such as adherence tracking and remote clinician alerts.

This convergence of patient-centric design, software-enabled functionalities, and value-driven reimbursement is propelling market entrants to rethink traditional competitive moats. Partnerships across technology vendors, pharmaceutical firms, and healthcare providers are proliferating, forging integrated offerings that deliver holistic diabetes management solutions. These developments herald a new paradigm in which smart insulin pens and pumps are not standalone products but pivotal nodes within an interconnected digital health infrastructure.

Assessing 2025 Tariff Impacts on Insulin Delivery Devices

The implementation of new tariffs on key components and subassemblies in 2025 has introduced a complex layer of cost considerations for manufacturers and suppliers of smart insulin delivery devices. Raw material costs, particularly for electronic sensors, microprocessors, and specialized plastics, have risen as import duties on semiconductors and polymer blends take effect. These increases are reverberating through the supply chain, prompting distributors to reassess pricing structures and contractual agreements with healthcare institutions.

In response, many device manufacturers are exploring the reshoring of certain production processes or diversifying their supplier base to mitigate exposure to tariff-induced cost spikes. Investment in in-country manufacturing capabilities is on the rise, driven by incentives from regional development agencies eager to attract advanced medical technology firms. Simultaneously, strategic sourcing from tariff-exempt trading partners has become a priority to preserve gross margins and maintain competitive price points.

Patients and payers are beginning to feel the impact as well. Insurance formularies and reimbursement schedules are under pressure to adjust for incremental device costs, potentially influencing formularies and patient co-pay structures. Industry players are countering this dynamic by emphasizing the long-term economic benefits of smart pens and pumps, such as reduced hospitalizations and improved glycemic control, to sustain value-based contracts despite the headwinds posed by elevated import duties.

Decoding Market Dynamics Through Multi-Dimensional Segmentation

A nuanced understanding of market segmentation reveals the multifaceted growth dynamics within the smart insulin device arena. When dissecting performance by product type, insulin pens dominate in terms of unit adoption due to their familiarity and cost efficiency, with reusable formats capturing a significant share as clinicians and patients prioritize sustainability. Pumps, meanwhile, are gaining traction among patients requiring precise basal and bolus management, driven by their advanced dosing algorithms and integration with continuous glucose monitoring systems.

Treatment type segmentation underscores the persistent demand for basal therapy solutions, which form the cornerstone of most insulin regimens by stabilizing fasting glucose levels. Bolus therapy devices are carving out their niche by facilitating rapid-acting insulin delivery during mealtime spikes, while combination therapy modalities are emerging as an attractive compromise, offering integrated sequential dosing capabilities for both basal and bolus requirements within a single platform.

Distribution channels also define unique pathways to market engagement. Hospital pharmacies continue to be the primary conduit for initial device provisioning in inpatient and acute settings, whereas online pharmacies are capitalizing on patient preference for convenience, direct-to-consumer models, and e-commerce platforms that deliver auto-replenishment subscriptions. Retail pharmacies remain a critical touchpoint, with chain outlets providing scale and brand recognition and independent stores offering personalized counseling.

Diabetes type segmentation sheds light on the specialized needs of distinct patient populations. Type 1 and type 2 cohorts differ markedly in dosing complexity and frequency, while gestational diabetes scenarios demand devices with rapid titration capabilities and enhanced safety safeguards for both mother and fetus. End user insights reveal that home use represents the lion’s share of demand as patients seek autonomy in self-administration, yet hospitals, clinics, and specialty diabetes centers are indispensable for initial training, device initiation, and complex case management.

Regional Market Highlights Revealing Distinct Growth Drivers

Geographic markets display divergent growth trajectories and regulatory landscapes that influence the adoption of smart insulin delivery devices. In the Americas, a high level of healthcare spending, robust reimbursement frameworks, and established digital infrastructure have fueled rapid uptake of connected pens and pumps. North American health systems are collaborating with technology firms to pilot remote monitoring programs that aim to reduce readmission rates and enhance patient adherence.

Europe, the Middle East, and Africa present a mosaic of reimbursement policies and regulatory requirements. Western European nations boast mature value-based procurement models and stringent data protection mandates, while emerging Middle Eastern markets are investing heavily in healthcare modernization initiatives. African markets, though nascent in smart device adoption, are witnessing pilot programs supported by global health organizations, focusing on rural telehealth applications to bridge access gaps.

The Asia-Pacific region exemplifies a broad spectrum of market maturity. Developed economies such as Japan and Australia combine advanced regulatory pathways with high digital health literacy, catalyzing strong demand for integrated insulin delivery systems. In contrast, Southeast Asian and South Asian markets are navigating affordability challenges, yet rapid urbanization, growing incidence of type 2 diabetes, and government-backed digital health strategies are creating fertile ground for future expansion.

Competitive Landscape Featuring Leading Stakeholder Strategies

The competitive landscape in smart insulin delivery is defined by a blend of established pharmaceutical giants and agile device-focused innovators. Leading insulin manufacturers are increasingly collaborating with technology partners to embed digital capabilities within their pen and pump portfolios, effectively merging therapeutic expertise with software proficiency. Concurrently, pure-play medical device companies are leveraging modular design approaches, enabling rapid iteration and seamless integration with third-party monitoring platforms.

Strategic alliances, joint ventures, and selective acquisitions are reshaping market share dynamics. Companies are prioritizing the consolidation of intellectual property around smart dosing algorithms, cloud-based analytics, and interoperability standards. In addition, several players are investing in patient support services that extend beyond device provisioning to include telecoaching, adherence reminders, and remote clinical consultations.

Innovation is also driving competitive differentiation. Novel delivery mechanisms that reduce injection pain, extended-wear infusion sets for pumps, and closed-loop systems that automatically adjust insulin dosing based on continuous glucose readings are breaking new ground. Market leaders are channeling resources into real-world evidence generation, seeking to substantiate claims of improved clinical outcomes and total cost of ownership, thereby reinforcing their value proposition with payers and health systems alike.

Strategic Imperatives to Capitalize on Emerging Opportunities

To navigate the complexities of the smart insulin delivery market, industry leaders must embrace targeted strategic actions that align with evolving stakeholder expectations. First, integrating device interoperability with widely adopted continuous glucose monitoring platforms will enhance user experience and bolster adoption rates by simplifying data consolidation across disparate systems. Investing in universal connectivity standards can position organizations as ecosystem enablers rather than isolated product vendors.

Second, forging partnerships with payers and health systems to co-develop value-based reimbursement models will be critical. Demonstrating quantifiable reductions in hospital admissions and long-term complications can unlock outcome-focused contracts that reward device performance instead of sheer volume. These collaborations should be underpinned by robust real-world data collection and analysis capabilities.

Third, diversifying manufacturing footprints to balance cost efficiency with supply chain resilience will safeguard against tariff disruptions and raw material bottlenecks. Establishing regional production hubs near key markets can minimize logistical delays and foster closer collaboration with local regulatory bodies.

Lastly, deepening patient engagement through differentiated digital services-such as predictive adherence alerts, gamified education modules, and telehealth integration-will drive sustained market share gains. By prioritizing the user journey and delivering personalized support, companies can cultivate brand loyalty and unlock new revenue streams beyond device sales.

Robust Research Framework Underpinning Market Intelligence

This study synthesizes insights gathered through a rigorous two-pronged research framework. The quantitative component comprises systematic analysis of industry databases, regulatory filings, and proprietary transaction records to establish baseline market metrics. Complementing this, a series of semi-structured interviews with endocrinologists, diabetes educators, procurement specialists, and technology integrators provided qualitative depth and context.

To ensure data integrity, triangulation techniques were applied, cross-referencing secondary sources with primary inputs. An iterative validation process engaged subject matter experts to vet assumptions and refine thematic findings. Additionally, a review of scientific literature and emerging clinical trial data offered perspective on evolving safety profiles and therapeutic outcomes associated with smart insulin delivery modalities.

Geographic and segmentation analyses were conducted using a combination of top-down and bottom-up methodologies, enabling precise delineation of market share across device types, treatment paradigms, distribution channels, diabetes categories, and end-user segments. This approach facilitated the identification of nuanced growth pockets and enabled forecasts to reflect both macroeconomic factors and granular market dynamics.

Converging Insights Informing the Future of Insulin Delivery

The synthesis of technological innovation, regulatory evolution, and patient-centered care models underscores the critical juncture at which the smart insulin delivery market stands. As connected pens and pumps transition from novel offerings to standard-of-care tools, stakeholders must remain vigilant to shifts in cost structures driven by trade policies, the emergence of interoperability standards, and the imperative for outcome-oriented solutions.

Segmentation and regional analyses spotlight the heterogeneity of market drivers, revealing areas of immediate opportunity as well as pockets requiring strategic investment to overcome infrastructure or reimbursement hurdles. Competitive pressures will intensify as established players and nimble entrants vie to capture share, each leveraging digital ecosystems to differentiate their value propositions.

Actionable recommendations emphasize the necessity of cross-sector partnerships, data-driven reimbursement models, and patient engagement strategies as foundational pillars for sustainable growth. By adhering to a robust research methodology, decision-makers gain the clarity required to prioritize initiatives that align with both clinical efficacy and economic viability. This concluding synthesis sets the stage for informed strategic planning and operational execution in a market defined by rapid change and high stakes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Insulin Pens
      • Prefilled Pens
      • Reusable Pens
    • Insulin Pumps
  • Treatment Type
    • Basal Therapy
    • Bolus Therapy
    • Combination Therapy
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
      • Direct To Consumer
      • E-Commerce Platforms
    • Retail Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • Diabetes Type
    • Gestational
    • Type 1
    • Type 2
  • End User
    • Home Use
    • Hospitals And Clinics
    • Specialty Diabetes Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • F. Hoffmann-La Roche AG
  • Ypsomed Holding AG
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Biocorp S.A.
  • Bigfoot Biomedical, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Smart Insulin Pens & Pumps Market, by Product Type
8.1. Introduction
8.2. Insulin Pens
8.2.1. Prefilled Pens
8.2.2. Reusable Pens
8.3. Insulin Pumps
9. Smart Insulin Pens & Pumps Market, by Treatment Type
9.1. Introduction
9.2. Basal Therapy
9.3. Bolus Therapy
9.4. Combination Therapy
10. Smart Insulin Pens & Pumps Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.3.1. Direct to Consumer
10.3.2. E-Commerce Platforms
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Smart Insulin Pens & Pumps Market, by Diabetes Type
11.1. Introduction
11.2. Gestational
11.3. Type 1
11.4. Type 2
12. Smart Insulin Pens & Pumps Market, by End User
12.1. Introduction
12.2. Home Use
12.3. Hospitals and Clinics
12.4. Specialty Diabetes Centers
13. Americas Smart Insulin Pens & Pumps Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Smart Insulin Pens & Pumps Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Smart Insulin Pens & Pumps Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. Insulet Corporation
16.3.3. Tandem Diabetes Care, Inc.
16.3.4. F. Hoffmann-La Roche AG
16.3.5. Ypsomed Holding AG
16.3.6. Novo Nordisk a/S
16.3.7. Eli Lilly and Company
16.3.8. Sanofi S.A.
16.3.9. Biocorp S.A.
16.3.10. Bigfoot Biomedical, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SMART INSULIN PENS & PUMPS MARKET MULTI-CURRENCY
FIGURE 2. SMART INSULIN PENS & PUMPS MARKET MULTI-LANGUAGE
FIGURE 3. SMART INSULIN PENS & PUMPS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SMART INSULIN PENS & PUMPS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SMART INSULIN PENS & PUMPS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. SMART INSULIN PENS & PUMPS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY PREFILLED PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY BASAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY BOLUS THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY GESTATIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TYPE 1, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TYPE 2, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY HOME USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL SMART INSULIN PENS & PUMPS MARKET SIZE, BY SPECIALTY DIABETES CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 53. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 54. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 57. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 58. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 61. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 103. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 104. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 106. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 107. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 111. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 115. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 127. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 130. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 131. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 135. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 138. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 139. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 167. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 168. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 170. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 171. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 183. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 184. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 186. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 187. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 191. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 194. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 214. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 215. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 218. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 223. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 226. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 239. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 240. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 246. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 247. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 248. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 250. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 251. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC SMART INSULIN PENS & PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 270. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 271. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 272. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 275. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 276. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 278. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 280. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 283. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 284. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 288. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 291. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 292. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY INSULIN PENS, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY ONLINE PHARMACY, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA SMART INSULIN PENS & PUMPS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 318. THAILAND SMART INSULIN PENS & PUMPS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLI

Companies Mentioned

The companies profiled in this Smart Insulin Pens & Pumps market report include:
  • Medtronic plc
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • F. Hoffmann-La Roche AG
  • Ypsomed Holding AG
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • Sanofi S.A.
  • Biocorp S.A.
  • Bigfoot Biomedical, Inc.

Methodology

Loading
LOADING...

Table Information